Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Medical Therapy in Pregnant Women with Diabetes

Lee SH, Ahn J, Kim J

Pregnant women with diabetes are at greater risk for adverse outcomes, such as miscarriage, macrosomia, and preterm birth. Advances in the care of diabetes have reduced maternal and perinatal mortality...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of an Insulin Analogue in Six Hypoglycemia-Prone Hemodialysis Patients with Type 2 Diabetes

Kim GE, Hong SB, Han JY, Jang JH, Yang DH, Lee SW, Song JH

  • KMID: 2263415
  • Korean J Med.
  • 2012 Nov;83(5):647-653.
Day-to-day insulin requirements often change due to subtle variations in insulin metabolism in patients with type 2 diabetes undergoing hemodialysis. In such cases, intra-hemodialysis hypoglycemia frequently occurs and is a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Maintenance of Insulin Therapy by Desensitization in Insulin Allergy Patient

Hong JH, Lee JH, Shin JH, Kim DP, Ko BS, Kim BJ, Kim HJ, Park KS

Allergic reaction to human insulin is uncommon. But they can cause mild to severe symptoms such as dyspnea, hypotensive shock, etc. Here we report the case of a patient with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Determining the Factors that Influence the Insulin Requirements in Type 2 Diabetic Patients

Chung JO, Cho DH, Chung DJ, Chung MY

BACKGROUND: The initial insulin dose is often determined by clinical experience or with a formula using the body weight. However, it may be difficult to determine the initial insulin dose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Insulin Glargine in Adolescents with Uncontrolled type 1 Diabetes Mellitus

Lee YJ, Ko JM, Yoo HW

  • KMID: 2321954
  • J Korean Soc Pediatr Endocrinol.
  • 2008 Jun;13(1):36-40.
PURPOSE: With long acting time of 24 hours and no peak concentration, insulin glargine (Lantus(R), Aventis Pharma, Frankfurt, Germany) is preferably used as basal insulin to control fasting glucose level....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment

Yang Y, Shin JA, Yang HK, Lee SH, Ko SH, Ahn YB, Yoon KH, Cho JH

BACKGROUND: There were a limited number of studies about β-cell function after insulin initiation in patients exposed to long durations of sulfonylurea treatment. In this study, we aimed to evaluate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus

Choe EY, Lee YH, Lee BW, Kang ES, Cha BS, Lee HC

BACKGROUND: The present study investigates the efficacy in glycemic control by adding once-a-day glulisine to glargine as a basal plus regimen and factors influencing glycemic control with the basal plus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data

Park S, Rhee SY, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT

BACKGROUND: This is part of a prospective study carried out as a national project to secure standardized public resources for type 2 diabetes mellitus (T2DM) patients in Korea. We compared...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Efficacy of Modern Insulin Analogues

Yoo HJ, Park KY, Park KS, Ahn KJ, Min KW, Park JH, Chang SA, Cha BS, Kim DJ, Kim YS, Oh TK, Chon S, Nam-Goong , Kim MJ, Kim HS, Choi YS, Ahn YH, Lee S, Baik SH

BACKGROUND: A1chieve(R) was a noninterventional study evaluating the clinical safety and efficacy of biphasic insulin aspart 30, insulin detemir, and insulin aspart. METHODS: Korean type 2 diabetes patients who have not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr